 | • レポートコード：MRC2-11QY04330 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は閉経後骨粗鬆症治療薬のグローバル市場について調査・分析したレポートです。種類別（ビスフォスフォネート、ホルモン、ラネル酸ストロンチウム、ラロキシフェン、デノスマブ、その他）市場規模、用途別（病院薬局、オンライン薬局、小売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別閉経後骨粗鬆症治療薬の競争状況、市場シェア ・世界の閉経後骨粗鬆症治療薬市場：種類別市場規模 2015年-2020年（ビスフォスフォネート、ホルモン、ラネル酸ストロンチウム、ラロキシフェン、デノスマブ、その他） ・世界の閉経後骨粗鬆症治療薬市場：種類別市場規模予測 2021年-2026年（ビスフォスフォネート、ホルモン、ラネル酸ストロンチウム、ラロキシフェン、デノスマブ、その他） ・世界の閉経後骨粗鬆症治療薬市場：用途別市場規模 2015年-2020年（病院薬局、オンライン薬局、小売薬局） ・世界の閉経後骨粗鬆症治療薬市場：用途別市場規模予測 2021年-2026年（病院薬局、オンライン薬局、小売薬局） ・北米の閉経後骨粗鬆症治療薬市場分析：米国、カナダ ・ヨーロッパの閉経後骨粗鬆症治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの閉経後骨粗鬆症治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の閉経後骨粗鬆症治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの閉経後骨粗鬆症治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Eli Lilly、Pfizer、F. Hoffman La Roche、Procter & Gamble、Merck ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Osteoporosis is a disease where increased bone weakness increases the risk of a broken bone.
The postmenopausal osteoporosis therapeutics market is expected to register a fast growth over the forecast period owing to the increasing prevalence of postmenopausal osteoporosis disease.
Market Analysis and Insights: Global Postmenopausal Osteoporosis Therapeutics Market
The global Postmenopausal Osteoporosis Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Postmenopausal Osteoporosis Therapeutics Scope and Market Size
Postmenopausal Osteoporosis Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Postmenopausal Osteoporosis Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Eli Lilly
Pfizer
F. Hoffman La Roche
Procter & Gamble
Merck
…
Market segment by Type, the product can be split into
Bisphosphonates
Hormones
Strontium Ranelate
Raloxifene
Denosumab
Others
Market segment by Application, split into
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Postmenopausal Osteoporosis Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Postmenopausal Osteoporosis Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Bisphosphonates
1.4.3 Hormones
1.4.4 Strontium Ranelate
1.4.5 Raloxifene
1.4.6 Denosumab
1.4.7 Others
1.5 Market by Application
1.5.1 Global Postmenopausal Osteoporosis Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Online Pharmacies
1.5.4 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Postmenopausal Osteoporosis Therapeutics Market Perspective (2015-2026)
2.2 Global Postmenopausal Osteoporosis Therapeutics Growth Trends by Regions
2.2.1 Postmenopausal Osteoporosis Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Postmenopausal Osteoporosis Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Postmenopausal Osteoporosis Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Postmenopausal Osteoporosis Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Postmenopausal Osteoporosis Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Postmenopausal Osteoporosis Therapeutics Players by Market Size
3.1.1 Global Top Postmenopausal Osteoporosis Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Postmenopausal Osteoporosis Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Postmenopausal Osteoporosis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Postmenopausal Osteoporosis Therapeutics Market Concentration Ratio
3.2.1 Global Postmenopausal Osteoporosis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Postmenopausal Osteoporosis Therapeutics Revenue in 2019
3.3 Postmenopausal Osteoporosis Therapeutics Key Players Head office and Area Served
3.4 Key Players Postmenopausal Osteoporosis Therapeutics Product Solution and Service
3.5 Date of Enter into Postmenopausal Osteoporosis Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Postmenopausal Osteoporosis Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Postmenopausal Osteoporosis Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Postmenopausal Osteoporosis Therapeutics Market Size by Application (2015-2020)
5.2 Global Postmenopausal Osteoporosis Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Postmenopausal Osteoporosis Therapeutics Market Size (2015-2020)
6.2 Postmenopausal Osteoporosis Therapeutics Key Players in North America (2019-2020)
6.3 North America Postmenopausal Osteoporosis Therapeutics Market Size by Type (2015-2020)
6.4 North America Postmenopausal Osteoporosis Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Postmenopausal Osteoporosis Therapeutics Market Size (2015-2020)
7.2 Postmenopausal Osteoporosis Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Postmenopausal Osteoporosis Therapeutics Market Size by Type (2015-2020)
7.4 Europe Postmenopausal Osteoporosis Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Postmenopausal Osteoporosis Therapeutics Market Size (2015-2020)
8.2 Postmenopausal Osteoporosis Therapeutics Key Players in China (2019-2020)
8.3 China Postmenopausal Osteoporosis Therapeutics Market Size by Type (2015-2020)
8.4 China Postmenopausal Osteoporosis Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Postmenopausal Osteoporosis Therapeutics Market Size (2015-2020)
9.2 Postmenopausal Osteoporosis Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Postmenopausal Osteoporosis Therapeutics Market Size by Type (2015-2020)
9.4 Japan Postmenopausal Osteoporosis Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Postmenopausal Osteoporosis Therapeutics Market Size (2015-2020)
10.2 Postmenopausal Osteoporosis Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Postmenopausal Osteoporosis Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Postmenopausal Osteoporosis Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Postmenopausal Osteoporosis Therapeutics Market Size (2015-2020)
11.2 Postmenopausal Osteoporosis Therapeutics Key Players in India (2019-2020)
11.3 India Postmenopausal Osteoporosis Therapeutics Market Size by Type (2015-2020)
11.4 India Postmenopausal Osteoporosis Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Postmenopausal Osteoporosis Therapeutics Market Size (2015-2020)
12.2 Postmenopausal Osteoporosis Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Postmenopausal Osteoporosis Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Postmenopausal Osteoporosis Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Eli Lilly
13.1.1 Eli Lilly Company Details
13.1.2 Eli Lilly Business Overview
13.1.3 Eli Lilly Postmenopausal Osteoporosis Therapeutics Introduction
13.1.4 Eli Lilly Revenue in Postmenopausal Osteoporosis Therapeutics Business (2015-2020))
13.1.5 Eli Lilly Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview
13.2.3 Pfizer Postmenopausal Osteoporosis Therapeutics Introduction
13.2.4 Pfizer Revenue in Postmenopausal Osteoporosis Therapeutics Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 F. Hoffman La Roche
13.3.1 F. Hoffman La Roche Company Details
13.3.2 F. Hoffman La Roche Business Overview
13.3.3 F. Hoffman La Roche Postmenopausal Osteoporosis Therapeutics Introduction
13.3.4 F. Hoffman La Roche Revenue in Postmenopausal Osteoporosis Therapeutics Business (2015-2020)
13.3.5 F. Hoffman La Roche Recent Development
13.4 Procter & Gamble
13.4.1 Procter & Gamble Company Details
13.4.2 Procter & Gamble Business Overview
13.4.3 Procter & Gamble Postmenopausal Osteoporosis Therapeutics Introduction
13.4.4 Procter & Gamble Revenue in Postmenopausal Osteoporosis Therapeutics Business (2015-2020)
13.4.5 Procter & Gamble Recent Development
13.5 Merck
13.5.1 Merck Company Details
13.5.2 Merck Business Overview
13.5.3 Merck Postmenopausal Osteoporosis Therapeutics Introduction
13.5.4 Merck Revenue in Postmenopausal Osteoporosis Therapeutics Business (2015-2020)
13.5.5 Merck Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Postmenopausal Osteoporosis Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Postmenopausal Osteoporosis Therapeutics Revenue
Table 3. Ranking of Global Top Postmenopausal Osteoporosis Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Postmenopausal Osteoporosis Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Bisphosphonates
Table 6. Key Players of Hormones
Table 7. Key Players of Strontium Ranelate
Table 8. Key Players of Raloxifene
Table 9. Key Players of Denosumab
Table 10. Key Players of Others
Table 11. Global Postmenopausal Osteoporosis Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Postmenopausal Osteoporosis Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Postmenopausal Osteoporosis Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Postmenopausal Osteoporosis Therapeutics Market Share by Regions (2015-2020)
Table 15. Global Postmenopausal Osteoporosis Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Postmenopausal Osteoporosis Therapeutics Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Postmenopausal Osteoporosis Therapeutics Market Growth Strategy
Table 21. Main Points Interviewed from Key Postmenopausal Osteoporosis Therapeutics Players
Table 22. Global Postmenopausal Osteoporosis Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 23. Global Postmenopausal Osteoporosis Therapeutics Market Share by Players (2015-2020)
Table 24. Global Top Postmenopausal Osteoporosis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Postmenopausal Osteoporosis Therapeutics as of 2019)
Table 25. Global Postmenopausal Osteoporosis Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Postmenopausal Osteoporosis Therapeutics Product Solution and Service
Table 28. Date of Enter into Postmenopausal Osteoporosis Therapeutics Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Postmenopausal Osteoporosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 31. Global Postmenopausal Osteoporosis Therapeutics Market Size Share by Type (2015-2020)
Table 32. Global Postmenopausal Osteoporosis Therapeutics Revenue Market Share by Type (2021-2026)
Table 33. Global Postmenopausal Osteoporosis Therapeutics Market Size Share by Application (2015-2020)
Table 34. Global Postmenopausal Osteoporosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 35. Global Postmenopausal Osteoporosis Therapeutics Market Size Share by Application (2021-2026)
Table 36. North America Key Players Postmenopausal Osteoporosis Therapeutics Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Postmenopausal Osteoporosis Therapeutics Market Share (2019-2020)
Table 38. North America Postmenopausal Osteoporosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 39. North America Postmenopausal Osteoporosis Therapeutics Market Share by Type (2015-2020)
Table 40. North America Postmenopausal Osteoporosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 41. North America Postmenopausal Osteoporosis Therapeutics Market Share by Application (2015-2020)
Table 42. Europe Key Players Postmenopausal Osteoporosis Therapeutics Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Postmenopausal Osteoporosis Therapeutics Market Share (2019-2020)
Table 44. Europe Postmenopausal Osteoporosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Postmenopausal Osteoporosis Therapeutics Market Share by Type (2015-2020)
Table 46. Europe Postmenopausal Osteoporosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Postmenopausal Osteoporosis Therapeutics Market Share by Application (2015-2020)
Table 48. China Key Players Postmenopausal Osteoporosis Therapeutics Revenue (2019-2020) (Million US$)
Table 49. China Key Players Postmenopausal Osteoporosis Therapeutics Market Share (2019-2020)
Table 50. China Postmenopausal Osteoporosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 51. China Postmenopausal Osteoporosis Therapeutics Market Share by Type (2015-2020)
Table 52. China Postmenopausal Osteoporosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 53. China Postmenopausal Osteoporosis Therapeutics Market Share by Application (2015-2020)
Table 54. Japan Key Players Postmenopausal Osteoporosis Therapeutics Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Postmenopausal Osteoporosis Therapeutics Market Share (2019-2020)
Table 56. Japan Postmenopausal Osteoporosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Postmenopausal Osteoporosis Therapeutics Market Share by Type (2015-2020)
Table 58. Japan Postmenopausal Osteoporosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Postmenopausal Osteoporosis Therapeutics Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Postmenopausal Osteoporosis Therapeutics Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Postmenopausal Osteoporosis Therapeutics Market Share (2019-2020)
Table 62. Southeast Asia Postmenopausal Osteoporosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Postmenopausal Osteoporosis Therapeutics Market Share by Type (2015-2020)
Table 64. Southeast Asia Postmenopausal Osteoporosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Postmenopausal Osteoporosis Therapeutics Market Share by Application (2015-2020)
Table 66. India Key Players Postmenopausal Osteoporosis Therapeutics Revenue (2019-2020) (Million US$)
Table 67. India Key Players Postmenopausal Osteoporosis Therapeutics Market Share (2019-2020)
Table 68. India Postmenopausal Osteoporosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 69. India Postmenopausal Osteoporosis Therapeutics Market Share by Type (2015-2020)
Table 70. India Postmenopausal Osteoporosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 71. India Postmenopausal Osteoporosis Therapeutics Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Postmenopausal Osteoporosis Therapeutics Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Postmenopausal Osteoporosis Therapeutics Market Share (2019-2020)
Table 74. Central & South America Postmenopausal Osteoporosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Postmenopausal Osteoporosis Therapeutics Market Share by Type (2015-2020)
Table 76. Central & South America Postmenopausal Osteoporosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Postmenopausal Osteoporosis Therapeutics Market Share by Application (2015-2020)
Table 78. Eli Lilly Company Details
Table 79. Eli Lilly Business Overview
Table 80. Eli Lilly Product
Table 81. Eli Lilly Revenue in Postmenopausal Osteoporosis Therapeutics Business (2015-2020) (Million US$)
Table 82. Eli Lilly Recent Development
Table 83. Pfizer Company Details
Table 84. Pfizer Business Overview
Table 85. Pfizer Product
Table 86. Pfizer Revenue in Postmenopausal Osteoporosis Therapeutics Business (2015-2020) (Million US$)
Table 87. Pfizer Recent Development
Table 88. F. Hoffman La Roche Company Details
Table 89. F. Hoffman La Roche Business Overview
Table 90. F. Hoffman La Roche Product
Table 91. F. Hoffman La Roche Revenue in Postmenopausal Osteoporosis Therapeutics Business (2015-2020) (Million US$)
Table 92. F. Hoffman La Roche Recent Development
Table 93. Procter & Gamble Company Details
Table 94. Procter & Gamble Business Overview
Table 95. Procter & Gamble Product
Table 96. Procter & Gamble Revenue in Postmenopausal Osteoporosis Therapeutics Business (2015-2020) (Million US$)
Table 97. Procter & Gamble Recent Development
Table 98. Merck Company Details
Table 99. Merck Business Overview
Table 100. Merck Product
Table 101. Merck Revenue in Postmenopausal Osteoporosis Therapeutics Business (2015-2020) (Million US$)
Table 102. Merck Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Postmenopausal Osteoporosis Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Bisphosphonates Features
Figure 3. Hormones Features
Figure 4. Strontium Ranelate Features
Figure 5. Raloxifene Features
Figure 6. Denosumab Features
Figure 7. Others Features
Figure 8. Global Postmenopausal Osteoporosis Therapeutics Market Share by Application: 2020 VS 2026
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Postmenopausal Osteoporosis Therapeutics Report Years Considered
Figure 13. Global Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Postmenopausal Osteoporosis Therapeutics Market Share by Regions: 2020 VS 2026
Figure 15. Global Postmenopausal Osteoporosis Therapeutics Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Postmenopausal Osteoporosis Therapeutics Market Share by Players in 2019
Figure 18. Global Top Postmenopausal Osteoporosis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Postmenopausal Osteoporosis Therapeutics as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Postmenopausal Osteoporosis Therapeutics Revenue in 2019
Figure 20. North America Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Postmenopausal Osteoporosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
骨粗鬆症治療薬の世界市場（～2026年） Osteoporosis is a silent epidemic and as per the WHO declarations, it is a priority health issue. Osteoporosis is a disruption of bone architecture and decrease in bone mass, leading to a number of complications including increased chances of bone fractures and reduced bone strength. The most common…- 抗骨粗鬆症治療・骨折治癒の世界市場（～2026年） Osteoporosis disease is the most prevalent disease that occurs due to bone mineral density which causes heavy risk of fractures and bone fragility. The disease occurs mostly in spine, hip, shoulder and forearm.Hip fractures are most common as nearly one-third of patients lose mobility and need long-…
- 女性健康治療の世界市場（～2026年） Women's experience of health and disease differ from those of men, due to unique biological, social and behavioural conditions. Biological differences vary all the way from phenotype to the cellular, and manifest unique risks for the development of ill health. Rise in cases of infertility and increa…
- 女性健康の世界市場（～2026年） Women are more prone to certain diseases, such as osteoporosis, osteoarthritis, anemia, menstruation-related disorders, depression, and obesity. Hence, increase in incidence of these conditions is likely to boost the market in the coming years. Government and various private organizations are workin…
- 血友病A・B治療材料の世界市場（～2026年） Hemophilia is a rare, inherited disorder in which blood doesn’t clot normally due to the lack of sufficient blood clotting factor. Clotting factor is a protein required for blood clotting to occur normally. Novel treatments for people suffering from hemophilia and other different bleeding problems h…